NeuroVirt Limited
PrivateLast Round
Accelerator
May 28, 2024
Total Funding Raised
$373,000
Company Overview
NeuroVirt Limited operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Accelerator round in May 2024.
NeuroVirt Limited is a healthcare technology company that develops an extended reality (XR) neurorehabilitation platform for stroke survivors and patients with neurological conditions.
Sector
Healthcare & Life Sciences
Verticals
AR/VR Experiences, Medical Devices, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Hardware + Subscription, Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroVirt Limited Comparables
Compare NeuroVirt Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Reneural | 89% | |
| Kinesix XR | 86% | |
| Neuro Rehab VR | 85% |
For institutional investors. Book with your work email.
NeuroVirt Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 28, 2024 | ||||
| Grant | Jun 30, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NeuroVirt Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute for Health and Care Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2024
Funding round included Innovate UK and TMC Innovation.
- Jun 30, 2023
$187K grant from National Institute for Health and Care Research
For institutional investors. Book with your work email.
NeuroVirt Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeuroVirt Limited's valuation, stock price, and market status.
Is NeuroVirt Limited a public or private company?
NeuroVirt Limited is a private company.
What is the current stock price of NeuroVirt Limited?
NeuroVirt Limited is a private company, so its shares have no public market price. Caplight tracks NeuroVirt Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeuroVirt Limited worth (valuation)?
Valuation information for NeuroVirt Limited is not publicly available.
Can I buy NeuroVirt Limited stock?
NeuroVirt Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeuroVirt Limited's last funding round?
NeuroVirt Limited's most recent funding round was Accelerator on May 28, 2024.
Who are the main investors in NeuroVirt Limited?
Key investors in NeuroVirt Limited include National Institute for Health and Care Research.
Will NeuroVirt Limited IPO soon?
No public IPO plans have been announced for NeuroVirt Limited.
How can I track NeuroVirt Limited secondary market activity?
Caplight tracks bids, offers, and trades in NeuroVirt Limited's shares on secondary markets.